⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TRAW News
Traws Pharma, Inc. Common Stock
Traws Pharma Reports Third Quarter 2025 Results and Business Highlights
globenewswire.com
TRAW
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials
prnewswire.com
TRAW
TRAW
Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025
globenewswire.com
TRAW
Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives
globenewswire.com
TRAW